483 related articles for article (PubMed ID: 32933544)
1. Targeting Follistatin like 1 ameliorates liver fibrosis induced by carbon tetrachloride through TGF-β1-miR29a in mice.
Xu XY; Du Y; Liu X; Ren Y; Dong Y; Xu HY; Shi JS; Jiang D; Xu X; Li L; Xu ZH; Geng Y
Cell Commun Signal; 2020 Sep; 18(1):151. PubMed ID: 32933544
[TBL] [Abstract][Full Text] [Related]
2. Thymosin β4 suppresses CCl
Li H; Li Q; Zhang X; Zheng X; Zhang Q; Hao Z
J Gene Med; 2018 Sep; 20(9):e3043. PubMed ID: 29972714
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of Fstl1 attenuates hepatic stellate cell activation through the TGF‑β1/Smad3 signaling pathway.
Shang H; Liu X; Guo H
Mol Med Rep; 2017 Nov; 16(5):7119-7123. PubMed ID: 28901425
[TBL] [Abstract][Full Text] [Related]
4. Follistatin-Like 1 Promotes Bleomycin-Induced Pulmonary Fibrosis through the Transforming Growth Factor Beta 1/Mitogen-Activated Protein Kinase Signaling Pathway.
Jin YK; Li XH; Wang W; Liu J; Zhang W; Fang YS; Zhang ZF; Dai HP; Ning W; Wang C
Chin Med J (Engl); 2018 Aug; 131(16):1917-1925. PubMed ID: 30082522
[TBL] [Abstract][Full Text] [Related]
5. Epigenetically-Regulated MicroRNA-9-5p Suppresses the Activation of Hepatic Stellate Cells via TGFBR1 and TGFBR2.
Yu F; Chen B; Fan X; Li G; Dong P; Zheng J
Cell Physiol Biochem; 2017; 43(6):2242-2252. PubMed ID: 29073595
[TBL] [Abstract][Full Text] [Related]
6. Xia-yu-xue decoction (XYXD) reduces carbon tetrachloride (CCl4)-induced liver fibrosis through inhibition hepatic stellate cell activation by targeting NF-κB and TGF-β1 signaling pathways.
Liu C; Yuan X; Tao L; Cheng Z; Dai X; Sheng X; Xue D
BMC Complement Altern Med; 2015 Jun; 15():201. PubMed ID: 26122378
[TBL] [Abstract][Full Text] [Related]
7. Igf2bp2 knockdown improves CCl
Xu Z; He B; Jiang Y; Zhang M; Tian Y; Zhou N; Zhou Y; Chen M; Tang M; Gao J; Peng F
Int Immunopharmacol; 2022 Sep; 110():108987. PubMed ID: 35820364
[TBL] [Abstract][Full Text] [Related]
8. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
9. The mouse Anxa6/miR-9-5p/Anxa2 axis modulates TGF-β1-induced mouse hepatic stellate cell (mHSC) activation and CCl
Liao J; Zhang Z; Yuan Q; Luo L; Hu X
Toxicol Lett; 2022 Jun; 362():38-49. PubMed ID: 35483553
[TBL] [Abstract][Full Text] [Related]
10. TGF-β1 induces Fstl1 via the Smad3-c-Jun pathway in lung fibroblasts.
Zheng X; Qi C; Zhang S; Fang Y; Ning W
Am J Physiol Lung Cell Mol Physiol; 2017 Aug; 313(2):L240-L251. PubMed ID: 28495857
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-101 suppresses liver fibrosis by targeting the TGFβ signalling pathway.
Tu X; Zhang H; Zhang J; Zhao S; Zheng X; Zhang Z; Zhu J; Chen J; Dong L; Zang Y; Zhang J
J Pathol; 2014 Sep; 234(1):46-59. PubMed ID: 24817606
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-497 induced by Clonorchis sinensis enhances the TGF-β/Smad signaling pathway to promote hepatic fibrosis by targeting Smad7.
Zhou QY; Yang HM; Liu JX; Xu N; Li J; Shen LP; Zhang YZ; Koda S; Zhang BB; Yu Q; Chen JX; Zheng KY; Yan C
Parasit Vectors; 2021 Sep; 14(1):472. PubMed ID: 34521449
[TBL] [Abstract][Full Text] [Related]
13. LEFTY2 alleviates hepatic stellate cell activation and liver fibrosis by regulating the TGF-β1/Smad3 pathway.
Yang YR; Bu FT; Yang Y; Li H; Huang C; Meng XM; Zhang L; Lv XW; Li J
Mol Immunol; 2020 Oct; 126():31-39. PubMed ID: 32745796
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-34a-5p inhibits liver fibrosis by regulating TGF-β1/Smad3 pathway in hepatic stellate cells.
Feili X; Wu S; Ye W; Tu J; Lou L
Cell Biol Int; 2018 Sep; 42(10):1370-1376. PubMed ID: 29957876
[TBL] [Abstract][Full Text] [Related]
15. 4-methylumbelliferone Prevents Liver Fibrosis by Affecting Hyaluronan Deposition, FSTL1 Expression and Cell Localization.
Andreichenko IN; Tsitrina AA; Fokin AV; Gabdulkhakova AI; Maltsev DI; Perelman GS; Bulgakova EV; Kulikov AM; Mikaelyan AS; Kotelevtsev YV
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847129
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
[TBL] [Abstract][Full Text] [Related]
17. TGF-β- and lipopolysaccharide-induced upregulation of circular RNA PWWP2A promotes hepatic fibrosis via sponging miR-203 and miR-223.
Liu W; Feng R; Li X; Li D; Zhai W
Aging (Albany NY); 2019 Nov; 11(21):9569-9580. PubMed ID: 31719209
[TBL] [Abstract][Full Text] [Related]
18. Sauchinone attenuates liver fibrosis and hepatic stellate cell activation through TGF-β/Smad signaling pathway.
Lee JH; Jang EJ; Seo HL; Ku SK; Lee JR; Shin SS; Park SD; Kim SC; Kim YW
Chem Biol Interact; 2014 Dec; 224():58-67. PubMed ID: 25451574
[TBL] [Abstract][Full Text] [Related]
19. CAT1 silencing inhibits TGF-β1-induced mouse hepatic stellate cell activation in vitro and hepatic fibrosis in vivo.
Peng F; Tian Y; Ma J; Xu Z; Wang S; Tang M; Lei J; Gong G; Jiang Y
Cytokine; 2020 Dec; 136():155288. PubMed ID: 32980687
[TBL] [Abstract][Full Text] [Related]
20. BMP-2 restoration aids in recovery from liver fibrosis by attenuating TGF-β1 signaling.
Chung YH; Huang YH; Chu TH; Chen CL; Lin PR; Huang SC; Wu DC; Huang CC; Hu TH; Kao YH; Tai MH
Lab Invest; 2018 Aug; 98(8):999-1013. PubMed ID: 29789683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
